| 1 |
32096857 | Screening for Cognitive Impairment in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. | 2020 Feb 25 |
1 |
| 2 |
31156366 | Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease. | 2019 |
1 |
| 3 |
30646339 | Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis. | 2018 Nov 2 |
2 |
| 4 |
21384431 | Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease. | 2012 Jan |
1 |
| 5 |
21220675 | Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. | 2011 Jan |
1 |
| 6 |
21419002 | [Clinical rehabilitative effect of memantine on cognitive and motor disorders in patients with Parkinson's disease]. | 2011 Feb 1 |
3 |
| 7 |
20033305 | Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia. | 2010 Feb |
2 |
| 8 |
19274640 | Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies. | 2009 May |
3 |
| 9 |
19008850 | [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia]. | 2008 |
1 |
| 10 |
17334274 | Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial. | 2007 Jan-Mar |
2 |
| 11 |
16625572 | Memantine for dementia. | 2006 Apr 19 |
1 |
| 12 |
12409683 | A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). | 2002 Nov |
1 |